These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16247100)

  • 41. Analysis of Clostridium difficile isolates from nosocomial outbreaks at three hospitals in diverse areas of Japan.
    Kato H; Kato N; Watanabe K; Yamamoto T; Suzuki K; Ishigo S; Kunihiro S; Nakamura I; Killgore GE; Nakamura S
    J Clin Microbiol; 2001 Apr; 39(4):1391-5. PubMed ID: 11283061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain.
    Huang H; Weintraub A; Fang H; Nord CE
    Scand J Infect Dis; 2009; 41(2):158-9. PubMed ID: 18846478
    [No Abstract]   [Full Text] [Related]  

  • 43. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.
    Bourgault AM; Lamothe F; Loo VG; Poirier L;
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3473-5. PubMed ID: 17005836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.
    Freeman J; Baines SD; Saxton K; Wilcox MH
    J Antimicrob Chemother; 2007 Jul; 60(1):83-91. PubMed ID: 17483547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The ABC's for eliminating Clostridium difficile.
    Butler T; Zips C
    Okla Nurse; 2010; 55(2):15. PubMed ID: 20722322
    [No Abstract]   [Full Text] [Related]  

  • 46. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP; Surawicz CM
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [C. difficile: new bacterial species significantly more pathogenic].
    Monschein M
    Kinderkrankenschwester; 2010 Dec; 29(12):522. PubMed ID: 21207759
    [No Abstract]   [Full Text] [Related]  

  • 48. Clostridium difficile--a new threat to public health?
    Brierley R
    Lancet Infect Dis; 2005 Sep; 5(9):535. PubMed ID: 16156003
    [No Abstract]   [Full Text] [Related]  

  • 49. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review.
    Simor AE
    J Am Geriatr Soc; 2010 Aug; 58(8):1556-64. PubMed ID: 20646106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Getting "C diff" under control.
    Metules T
    RN; 2004 Apr; Suppl():19-23; quiz 24-5. PubMed ID: 15132050
    [No Abstract]   [Full Text] [Related]  

  • 51. The challenges posed by reemerging Clostridium difficile infection.
    Blossom DB; McDonald LC
    Clin Infect Dis; 2007 Jul; 45(2):222-7. PubMed ID: 17578783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poor infection control, not fluoroquinolones, likely to be primary cause of Clostridium difficile-associated diarrhea outbreaks in Quebec.
    Weiss K
    Clin Infect Dis; 2006 Mar; 42(5):725-7; author reply 727-9. PubMed ID: 16447121
    [No Abstract]   [Full Text] [Related]  

  • 53. Clostridium difficile: an intestinal infection on the rise.
    Harv Mens Health Watch; 2010 Jun; 14(11):5-8. PubMed ID: 20597186
    [No Abstract]   [Full Text] [Related]  

  • 54. Reining in recurrent Clostridium difficile infection--who's at risk?
    Surawicz CM
    Gastroenterology; 2009 Apr; 136(4):1152-4. PubMed ID: 19250653
    [No Abstract]   [Full Text] [Related]  

  • 55. [Emergence of clostridium difficile ribotype 027 in Germany: epidemiological and clinical characteristics].
    Jansen A; Kleinkauf N; Weiss B; Zaiss NH; Witte W; Bornhofen B; Kist M; von Eichel-Streiber C; Neumann M; Michels H; Eckmanns T
    Z Gastroenterol; 2010 Sep; 48(9):1120-5. PubMed ID: 20839161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. C. difficile may have killed 2000 in Quebec: study.
    Eggertson L
    CMAJ; 2005 Oct; 173(9):1020-1. PubMed ID: 16179430
    [No Abstract]   [Full Text] [Related]  

  • 57. Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009.
    Roberts S; Heffernan H; Al Anbuky N; Pope C; Paviour S; Camp T; Swager T
    N Z Med J; 2011 Apr; 124(1332):45-51. PubMed ID: 21747423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clostridium difficile PCR ribotype 027 outbreaks in the Netherlands: recent surveillance data indicate that outbreaks are not easily controlled but interhospital transmission is limited.
    van den Hof S; van der Kooi T; van den Berg R; Kuijper EJ; Notermans DW
    Euro Surveill; 2006 Jan; 11(1):E060126.2. PubMed ID: 16801713
    [No Abstract]   [Full Text] [Related]  

  • 59. Editorial commentary: Clostridium difficile ribotype 027: an intrinsically virulent strain, but clinical virulence remains to be determined at the bedside.
    Goorhuis A
    Clin Infect Dis; 2015 Jul; 61(2):242-3. PubMed ID: 25828996
    [No Abstract]   [Full Text] [Related]  

  • 60. Risk factors for Clostridium difficile infection in a hepatology ward.
    Vanjak D; Girault G; Branger C; Rufat P; Valla DC; Fantin B
    Infect Control Hosp Epidemiol; 2007 Feb; 28(2):202-4. PubMed ID: 17265403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.